ArticleThe Lancet regional health. Europe2024

Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study.

Balazs Acs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.